REQUEST A DEMO
Total
USD $0.00
View basket Checkout now
Search more companies

Dr. Vaczine Szentlelek Gyogyszertar Bt. (Hungary)

Main Activities: Pharmacies and Drug Stores
Full name: Dr. Vaczine Szentlelek Gyogyszertar Bt. Profile Updated: September 26, 2025
Buy our report for this company USD 29.95 Most recent financial data: 2024 Available in: English & Hungarian Download a sample report

Dr. Vaczine Szentlelek Gyogyszertar Bt. is based in Hungary. The head office is in Gyor. It operates in the Pharmacies and Drug Stores industry. The company was established on January 03, 1997. There are currently 15 (2024) people employed by Dr. Vaczine Szentlelek Gyogyszertar Bt.. In 2024, the company reported a net sales revenue increase of 6.9%. Its’ total assets recorded a growth of 7.97%. Dr. Vaczine Szentlelek Gyogyszertar Bt.’s net profit margin increased by 0.23% in 2024.

Headquarters
Mecs L. u. 2/B.
Gyor; Gyor-Moson-Sopron; Postal Code: 9024

Contact Details: Purchase the Dr. Vaczine Szentlelek Gyogyszertar Bt. report to view the information.

Website: http://www.patika03.t-online.hu

Basic Information
Total Employees:
Purchase the Dr. Vaczine Szentlelek Gyogyszertar Bt. report to view the information.
Registered Capital:
Purchase the Dr. Vaczine Szentlelek Gyogyszertar Bt. report to view the information.
Financial Auditors:
Purchase the Dr. Vaczine Szentlelek Gyogyszertar Bt. report to view the information.
Incorporation Date:
January 03, 1997
Key Executives
Purchase this report to view the information.
Executive Officer
Ownership Details
Purchase this report to view the information.
Purchase this report to view the information.
Purchase this report to view the information.
Company Performance
Financial values in the chart are available after Dr. Vaczine Szentlelek Gyogyszertar Bt. report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency HUF. Absolute financial data is included in the purchased report.
Net sales revenue
6.9%▲
Total operating revenue
7.31%▲
Operating profit (EBIT)
6.96%▲
EBITDA
11.01%▲
Net Profit (Loss) for the Period
10.74%▲
Total Assets
7.97%▲
Total Equity
6.51%▲
Operating Profit Margin (ROS)
0%
Net Profit Margin
0.23%▲
Return on Equity (ROE)
0.64%▲
Quick Ratio
0.36%▲
Cash Ratio
0.35%▲

To view more information, Request a demonstration of the EMIS service

USD 29.95
Buy this company report
Need ongoing access to company, industry or country information?
Request a demo